Cantor Fitzgerald Analysts Give AVITA Med Ltd/S (AVMXY) a $65.00 Price Target
Cantor Fitzgerald set a $65.00 price target on AVITA Med Ltd/S (OTCMKTS:AVMXY) in a research report released on Thursday morning. The firm currently has a buy rating on the medical device company’s stock.
OTCMKTS:AVMXY opened at $1.75 on Thursday. AVITA Med Ltd/S has a twelve month low of $0.75 and a twelve month high of $2.15.
About AVITA Med Ltd/S
Featured Story: Return on Investment (ROI)
Receive News & Ratings for AVITA Med Ltd/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVITA Med Ltd/S and related companies with MarketBeat.com's FREE daily email newsletter.